What To Watch As Justices Take On 'Skinny Label' Case
The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the...To view the full article, register now.
Already a subscriber? Click here to view full article